FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and FDA to weigh easing limits on unproven peptides promoted by RFK Jr. FDA Finds Sterility Lapses at Compounding Facilities The Partnership for Safe Medicines posted on the topic LinkedIn BPC 157: Experimental Peptide Creates Risk for Athletes Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. Gray Market Peptides: So Much Hype, So Little Data